
Arthrosamid: Targeting Bilateral Knee Osteoarthritis for Balanced Relief and Greater Independence
Bilateral knee osteoarthritis causes significant pain and mobility challenges due to cartilage degradation in both knees. Achieving symmetry of relief is crucial to avoid imbalanced recovery and further complications. Arthrosamid, a polyacrylamide hydrogel injectable treatment, offers promising results by reducing pain and stiffness, facilitating improved joint function in both knees simultaneously. Clinical studies confirm its safety profile with no long-term adverse effects reported and efficacy lasting at least two years. Under the expert care of Professor Paul Lee at the London Cartilage Clinic, personalized Arthrosamid treatment helps patients maintain independence and engage in low-impact exercises. This innovative approach addresses the unique needs of bilateral knee OA patients, promoting better mobility and quality of life through balanced symptom management and tailored orthopaedic care.




